Showing 2101-2110 of 5696 results for "".
- Preliminary Results From Aldeyra’s Phase 3 Tranquility Trial Offer Promise for Patients With Dry Eye Syndrome, Says GlobalDatahttps://modernod.com/news/preliminary-results-from-aldeyras-phase-3-tranquility-trial-offer-promise-for-patients-with-dry-eye-syndrome-says-globaldata/2478786/Aldeyra Therapeutics recently announced topline results from the run-in cohort of the phase 3 trial evaluating reproxalap 0.25% for patients with dry eye syndrome (DES). The positive impact of the therapy on endpoints, such as ocular dryness, discomfort and Schirmer’s test, although preliminary,
- Wize Pharma Announces Positive Topline Results in Phase 4 Study of LO2A for Dry Eye in Patients with Sjögren’s Syndromehttps://modernod.com/news/wize-pharma-announces-positive-topline-results-in-phase-4-study-of-lo2a-for-dry-eye-in-patients-with-sjogrens-syndrome/2478529/Wize Pharma reported topline results from its phase 4 clinical trial of its in-license eye drop formula, LO2A, for the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren’s syndrome. The randomized, double-masked comparative study evaluated LO2A versus Alcon̵
- Aurinia Pharmaceuticals’ Dry Eye Drug Candidate Does Not Meet Primary Endpointhttps://modernod.com/news/aurinia-announces-outcome-of-audrey-clinical-trial-in-dry-eye-syndrome/2478487/Aurinia Pharmaceuticals announced topline data from the phase 2/3 AUDREY clinical study evaluating voclosporin ophthalmic solution (VOS) for the potential treatment of dry eye syndrome (DES). The trial did not achieve statistical significance on its primary endpoint of a 10 mm or greater improvem
- Oxurion NV to Provide Business and Clinical Update at AAO and OIS Meetings in San Franciscohttps://modernod.com/news/oxurion-nv-to-provide-business-and-clinical-update-at-aao-and-ois-meetings-in-san-francisco/2476969/Oxurion NV announces that the company will be providing a business and clinical update at the American Academy of Ophthalmology’s annual meeting (AAO) and Ophthalmology Innovation Summit (OIS@AAO) in San Francisco. Patrik De Haes, MD, CEO of Oxurion will be presenting the company’s b
- Haag-Streit Announces the Launch of the Ellex Eye Prime in UKhttps://modernod.com/news/haag-streit-uk-announces-the-launch-of-the-ellex-eye-prime/2476912/Haag-Streit UK (HS-UK) has announced the launch of the Eye Prime diagnostic ultrasound system in the UK. The Eye Prime is the next-generation ultrasound solution from Ellex. It features the industry’s first and only “six-ring phased annular array technology,” delivering crisp, high-de
- Ophtec’s Preloaded Capsular Tension Ring Ringject Receives Approval in Chinahttps://modernod.com/news/ophtecs-preloaded-capsular-tension-ring-ringject-receive-approval-in-china/2476275/Ophtec was granted CFDA approval for the preloaded capsular tension ring (CTR) Ringject in China. Ringject is a preloaded, single use capsular tension ring designed to be self-loading for surgical convenience. CTRs were originally introduced to strengthen the zonule in eyes with zonular de
- RGN-259 (Tβ4) Improves Clinically Important Dry Eye Efficacies in Comparison with Prescription Drugshttps://modernod.com/news/rgn-259-tceb24-improves-clinically-important-dry-eye-efficacies-in-comparison-with-prescription-drugs/2480019/RegeneRx Biopharmaceuticals announced that a new study was published comparing RGN-259 with currently approved prescription products for dry eye syndrome (DES). In the study, researchers demonstrated that after 10 days of treatment RGN-259 performed equal to or better than cyclosporine A (Restasi
- Oculus Incorporates Oculus Brasil in São Paulohttps://modernod.com/news/oculus-incorporates-oculus-brasil-in-sao-paulo/2480050/Oculus Optikgeräte, Germany, has incorporated Oculus Brasil Comercio Importação Exportação e Serviços de Equipamentos Médicos LTDA as its 10th international subsidiary. Located in São Paulo, Oculus Brasil will support new and existing customers throughout Brazil. Oculus Optikger
- NuSight Medical Launches NuLids for the Treatment of Dry Eyehttps://modernod.com/news/nusight-medical-launches-nulids-for-the-treatment-of-dry-eye/2480078/NuSight Medical has introduced The NuLids System, a doctor-prescribed, home-use medical device that efficiently treats dry eye by gently stimulating, de-capping, and rejuvenating the meibomian glands to a healthier state. The system was introduced at the American Optometric Association mee
- FDA Issues Draft Guidance to Accelerate Development of Gene Therapies Using Existing Scientific Knowledgehttps://modernod.com/news/fda-issues-draft-guidance-to-accelerate-development-of-gene-therapies-using-existing-scientific-knowledge/2487384/The FDA released draft guidance aimed at helping developers bring promising gene th